Results for “”

Entry Author Date Location
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Four More Through the IPO Door as Life Science Firms Raise $465M 06/20/19 National
Colorectal Cancer Data Spurs Pfizer to Pay $11.4B for Array Bio 06/17/19 Boulder/Denver
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More 06/14/19 National
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More 06/07/19 National
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
Study: Gene Edits in CRISPR Babies Could Boost Risk of Earlier Death 06/03/19 National
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer? 05/30/19 National
Immunotherapy Is Now Here For Breast Cancer. What Are Its Prospects? 05/29/19 National
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M 05/24/19 National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight 05/16/19 National
Stock, Profit & AI: Carbon Black CEO Reviews Year Since IPO 05/13/19 Boston
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials 05/09/19 National
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More 05/03/19 National
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments 05/03/19 National
Beyond Meat’s IPO Bags $241M to Make Plant-Based Burgers Mainstream 05/02/19 National
SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease? 05/02/19 National
Elanco Bolsters Pet Products Pipeline With $234M Deal for Aratana 04/26/19 Indiana
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
SPECIAL REPORT: 2019 Blockchain Outlook — Reality Check 04/23/19 National
Can We Afford to Be Cured? A Conversation With ICER’s Steve Pearson 04/23/19 Boston
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants 04/18/19 Boston
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy 04/15/19 National
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout 04/12/19 New York
Page 1 of 38 next page »